Patients must be deemed able to comply with the treatment plan and follow-up schedule
Patients who are able to comply with the protocol follow-up schedule
Able to understand and voluntarily sign the ICF and able to comply with the study visit schedule and the other protocol requirements.
Patients must be deemed able to comply with the treatment plan and follow-up schedule
Must be able to comply with the treatment plan and follow-up schedule
Willingness to give consent and comply with all study-related evaluations and treatment schedule; and
Ability to comply with the treatment schedule
Ability and willingness to obtain all required scans per study schedule
Able to comply with the treatment schedule
Willing to comply with proposed visit and treatment schedule
Ability to comply with the treatment schedule
Able to comply with the treatment schedule
Patient is unable or unwilling to provide written informed consent or comply with follow-up schedule
Willingness to follow the requirements of the intravenous ascorbic acid program schedule
Inability to give consent or adhere to follow-up schedule
Willing and able to comply with follow-up schedule
Willing and able to give written informed consent and comply with study visit schedule
Patients must comply with the treatment plan and follow-up schedule.
Willing and able to give written informed consent and comply with study visit schedule.
Willingness to follow study visit schedule, pregnancy precautions and other protocol requirements.
Patient must be able to give informed consent and comply with the treatment protocol and follow-up plan.
Patients must be willing and able to sign the informed consent form, and to follow the study visit schedule and other protocol requirements.
Inability to provide informed consent or to comply with the schedule of office and treatment visits
Able to comply with the treatment schedule
Unable to comply with the study follow-up schedule
Willing to give consent and comply with study-related evaluation and treatment schedule; and
Willing and able to comply with post-operative treatment protocol and follow-up visit schedule.
Able to comply with study visit schedule and assessments.
Patient is unwilling or unable to comply with the follow-up schedule
Unable to commit to intervention schedule ( weekly group meetings)
Chemotherapy treatment schedule <  weeks
Able to commit to a long term follow-up schedule
Patients must be deemed able to comply with the treatment plan and follow-up schedule
Unwilling or unable to comply with the follow-up schedule
Cannot commit to the intervention schedule
Inability to commit to the intervention schedule
Patients who are not planning to adhere to the required follow up schedule as outlined in this protocol
Patient is not likely to comply with the follow-up evaluation schedule
Patients who are not planning to adhere to the required follow up schedule as outlined in this protocol
Patient is not likely to comply with the follow-up evaluation schedule
